Advanced search
Publication Cover
Current Medical Research and Opinion Volume 18, 2002 - Issue 4
Submit an article Journal homepage
19
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Patient and Physician Satisfaction with Rofecoxib in Osteoarthritis: Results of a Post-marketing Surveillance Study in Primary Care in Germany

Josef Zacher Orthopädische Klinik, HELIOS Klinikum Berlin - Klinikum Buch, Hobrechtsfelder Chaussee 96, 13125 Berlin, GermanyCorrespondenceGermany.x+49-30-94016391;x+49-30-94016214;[email protected]
&
Manfred Schattenkirchner Medizinische Poliklinik der Universität, Rheumaeinheit, Pettenkoferstrasse 8a, 80336 München, Germany
Pages 229-236 | Published online: 26 Aug 2008

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

M. Corral, N. Ferko, S. Hollmann, A. Hogan, N. Jamous, J. Batiller & J. Shen. (2016) Clinician reported ease of use for a novel fibrin sealant patch for hemostasis: results from four randomized controlled trials. Current Medical Research and Opinion 32:2, pages 367-375.
Read now
Cesar R. Ramos-Remus, Elke Hunsche, Panagiotis Mavros, Julio Querol & Rafael Suarez. (2004) Evaluation of quality of life following treatment with etoricoxib in patients with arthritis or low-back pain: an open label, uncontrolled pilot study in Mexico. Current Medical Research and Opinion 20:5, pages 691-698.
Read now
Luis R. Arboleya, Enrique de la Figuera, María Soledad García & Belén Aragón. (2003) Experience of rofecoxib in patients with osteoarthritis previously treated with traditional non-steroidal anti-inflammatory drugs in Spain:results of phase 2 of theVICOXX study. Current Medical Research and Opinion 19:4, pages 288-297.
Read now

Articles from other publishers (5)

Naveen Ahuja, Amarjit Singh & Bhupinder Singh. (2003) Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. Journal of Pharmacy and Pharmacology 55:7, pages 859-894.
Crossref
Timothy D. Warner & Jane A. Mitchell. (2004) Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. The FASEB Journal 18:7, pages 790-804.
Crossref
David W J Clark, Deborah Layton & Saad A W Shakir. (2004) Do Some Inhibitors of COX-2 Increase the Risk of Thromboembolic Events?. Drug Safety 27:7, pages 427-456.
Crossref
Helmut Schmidt, Barry G Woodcock & Gerd Geisslinger. (2004) Benefit-Risk Assessment of Rofecoxib in the Treatment of Osteoarthritis. Drug Safety 27:3, pages 185-196.
Crossref
. (2003) Current Awareness: Pharmacoepidemiology and Drug Safety. Pharmacoepidemiology and Drug Safety 12:2, pages 161-176.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.